Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

GAZYVA Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GAZYVA

Patents:	24
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for GAZYVA

Mechanism of Action	CD20-directed Antibody Interactions

US Patents for GAZYVA

Subscribe to access the full database, or Request a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	See Pricing	Acerta Pharma B.V. (Oss, NL)	2034-06-17	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	See Pricing	Gilead Connecticut, Inc. (Foster City, CA)	2033-07-30	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	See Pricing	Immunomedics, Inc. (Morris Plains, NJ)	2032-12-13	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	See Pricing	Peking University Shenzhen Graduate School (Shenzhen, CN) Beijing Reciprocapharmaceuticals Co., Ltd. (Beijing, CN)	2031-10-25	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	See Pricing	Corning Incorporated (Corning, NY)	2033-04-24	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for GAZYVA

Subscribe to access the full database, or Request a Trial
Country	Patent Number	Estimated Expiration
European Patent Office	1937724	See Pricing
Israel	204066	See Pricing
European Patent Office	2396036	See Pricing
Israel	172402	See Pricing
Brazil	112015013444	See Pricing
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

Dow

Moodys

Mallinckrodt

Johnson and Johnson

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.